Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (323)

« Back to Publications

Parasitological efficacy of seasonal malaria chemoprevention in Nampula, northern Mozambique

Bonnington C. et al, (2026), Transactions of The Royal Society of Tropical Medicine and Hygiene, 120, 258 - 267

Transplacental Transfer of Lumefantrine, Mefloquine, and Piperaquine: A Comparison of Concentrations in Mothers, Neonates, and Cord Blood

Saito M. et al, (2026), Clinical Infectious Diseases, 82, e165 - e173

Pharmacometric evaluation of pre-referral rectal artesunate in children with severe malaria

Adehin A. et al, (2026)

Population pharmacokinetics of artemether–lumefantrine plus amodiaquine in patients with uncomplicated Plasmodium falciparum malaria

Ding J. et al, (2026), British Journal of Clinical Pharmacology, 92, 589 - 605

Repurposing Oxfendazole for Onchocerciasis: Population Pharmacokinetics of a Tablet Formulation in Healthy African Adults.

Assmus F. et al, (2026), CPT: pharmacometrics & systems pharmacology, 15

ssessing transporter‐mediated rifampin–linezolid interaction using physiologically‐based pharmacokinetic modelling

Nguyen HD. et al, (2026), British Journal of Clinical Pharmacology

Pharmacometric evaluation of sulfadoxine-pyrimethamine- amodiaquine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern Uganda.

Bonnington C. et al, (2025), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Population pharmacokinetics of lumefantrine in pregnant and non‐pregnant women with uncomplicated Plasmodium falciparum malaria in Western Kenya

Juma E. et al, (2025), British Journal of Clinical Pharmacology

Population pharmacokinetic-pharmacodynamic analysis of benznidazole monotherapy and combination therapy with fosravuconazole in chronic Chagas disease (BENDITA)

Assmus F. et al, (2025), PLOS Neglected Tropical Diseases, 19, e0013522 - e0013522

Weekly dihydroartemisinin-piperaquine versus monthly sulfadoxine-pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trial.

Idro R. et al, (2025), The Lancet. Infectious diseases, 25, 643 - 655

Potential interaction between clorsulon and ivermectin for malaria vector control.

Hongsuwong T. et al, (2025), Medical and veterinary entomology, 39, 393 - 397

Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials

Chan XHS. et al, (2025), The Lancet Microbe, 6, 101002 - 101002

Dose‐Optimization of a Novel Co‐Formulated Triple Combination Antimalarial Therapy: Artemether‐Lumefantrine‐Amodiaquine

Tarning J. et al, (2025), Clinical Pharmacology & Therapeutics, 117, 1248 - 1253

Pharmacokinetic-pharmacodynamic modeling of benznidazole and its antitrypanosomal activity in a murine model of chronic Chagas disease.

Assmus F. et al, (2025), PLoS neglected tropical diseases, 19

Use of population pharmacokinetic‐pharmacodynamic modelling to inform antimalarial dose optimization in infants

Banda CG. et al, (2025), British Journal of Clinical Pharmacology, 91, 968 - 980

Load More

1
2
3
4
5
6
7
...
»